AAD 2024 Insights
Avatar

AAD 2024 Insights: The Latest Advances in the Treatment of Melanoma

By AAD 2024 Insights FEATURING Vernon Sondak
By AAD 2024 Insights FEATURING Vernon Sondak
441 views
March 11, 2024
1 Comment
Login to view comments. Click here to Login

Related Content

AUTOPLAY
25:57
Masterclasses in Dermatology

Imaging Considerations for the Dermatologist

Feat. C. Bakewell
12:46
Stanford Medicine

FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …

Feat. A. Betof Warner
21:35
EADV 2022 Conference Coverage

How to Manage: Melanonychia

Feat. M. Starace
24:14
Masterclasses in Dermatology

Advances in the Treatment of Melanoma

Feat. D. Fisher
08:48
David Polsky

Promoting Skin Self-Exam for the Secondary Prevention of Melanoma

23:20
Masterclasses in Dermatology

Medical Advances in the Treatment of Melanoma

Feat. D. Fisher
13:12
2023 Year in Review

Year in Review: Surgical Treatment of Acral Melanoma

Feat. M. Leventer
20:55
2023 West Oncology Conference

2023 West Oncology Conference: Melanoma Updates

Feat. M. Mooradian
29:01
EADV 2023 Insights

EADV 2023 Insights: How to Avoid Mistreatment of Neoplastic Lesions

Feat. I. Zalaudek
20:32
Melanoma Bridge 2023

Targeted Therapy in BRAF-Mutated Metastatic Melanoma

Feat. R. Dummer
29:40
Melanoma 2023: 33rd Annual Cutaneous Malignancy Update

Melanoma, the Primary Lesion: Biopsy, Excision, and Mohs Surgery in …

Feat. D. Kent
10:39
Moffitt Cancer Center

Clinical Implications of COMBI-d and COMBI-v Trials on OS in Patient…

Feat. A. Tarhini
27:29
Total Health

2023 ASCO® Direct Philadelphia: Melanoma Updates

Feat. M. Orloff
07:53
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "aTezolizumab, bevAcizumab, and Cobimetinib…

Feat. E. Burton
12:09
Omid Hamid

Evolving Management of Melanoma CNS Metastases and the Impact of COM…

25:21
Melanoma 2023: 33rd Annual Cutaneous Malignancy Update

Treatment of Advanced Melanoma in 2023

Feat. K. Bollin
10:02
2023 Year in Review

Year in Review: Xeroderma Pigmentosum

Feat. A. Chacon
05:06
ASCO 2022 Conference Coverage

ASCO 2022 on RELATIVITY-047 Trial: Nivolumab + Relatlimab vs. Nivo i…

Feat. P. Rutkowski
15:46
Melanoma Bridge 2023

Treatment of Symptomatic Brain Metastases in Melanoma: Combination o…

Feat. H. Tawbi
07:25
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Brain Metastases & Survival Evaluation…

Feat. P. Ascierto